Literature DB >> 9080899

Erythema, skin cancer risk, and sunscreens.

M F Naylor.   

Abstract

Ultraviolet-induced erythema is now recognized as an important clinical marker for skin cancer risk. People with a history of repeated erythematous exposures to sunlight are more likely to develop both melanoma and nonmelanoma skin cancers. Is erythema the most important thing we need to be concerned about in terms of protecting the public from the harmful effects of sunlight? What do we know about UV-induced erythema, and why is it a powerful influence on skin cancer risk?

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080899

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

1.  Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis.

Authors:  J Y Tang; B J Hwang; J M Ford; P C Hanawalt; G Chu
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  Development of a whole-organism model to screen new compounds for sun protection.

Authors:  Yun-Hsin Wang; Chi-Chung Wen; Zhi-Shiang Yang; Chien-Chung Cheng; Jen-Ning Tsai; Chia-Chen Ku; Hsin-Ju Wu; Yau-Hung Chen
Journal:  Mar Biotechnol (NY)       Date:  2008-11-13       Impact factor: 3.619

3.  UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d.

Authors:  Stephan Ryser; Marlène Schuppli; Beatrice Gauthier; Dianelys R Hernandez; Olivier Roye; Daniel Hohl; Bruce German; James A Holzwarth; Angus M Moodycliffe
Journal:  J Invest Dermatol       Date:  2013-07-18       Impact factor: 8.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.